GENETIC POLYMORPHISM OF HUMAN COMPLEMENT PROTEINSHAUPTMANN G.1979; REV. FR. TRANSFUS. IMMUNO. HEMATOL.; FRA; DA. 1979; VOL. 22; NO 5; PP. 587-614; ABS. FRE; BIBL. 107 REF.Article

Structures et fonctions des récepteurs pour le C3, le troisième composant du complément, présents à la surface de cellules humaines = Structures and functions of the receptor for the third component of complement, C3, expressed or human cell surfaceFRADE, R.Transactions of the Zoological Society of London. 1985, Vol 33, Num 9, pp 869-872, issn 0084-5620Article

THE C5B-6 COMPLEX: REACTION WITH C7, C8, C9.PODACK ER; BIESECKER G; KOLB WP et al.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 121; NO 2; PP. 484-490; BIBL. 32 REF.Article

THE UNACTIVATED FORM OF THE FIRST COMPONENT OF HUMAN COMPLEMENT, C1.GIGLI I; PORTER RR; SIM RB et al.1976; BIOCHEM. J.; G.B.; DA. 1976; PP. 541-548; H.T. 2; BIBL. 19 REF.Article

STRUCTURE AND ACTIVATION OF THE EARLY COMPONENTS OF COMPLEMENT.PORTER RR.1977; FEDER. PROC.; U.S.A.; DA. 1977; VOL. 36; NO 9; PP. 2191-2196; BIBL. 48 REF.Article

Alternative complement pathway activation by C4b deposited during classical pathway activationMATSUSHITA, M; OKADA, H.The Journal of immunology (1950). 1986, Vol 136, Num 8, pp 2994-2998, issn 0022-1767Article

Complement and its fractions (C₃-C₄) pattern in subjects with neoplasiaMANGANO, A; MESSINA, L; BIRGILLITO, S et al.Journal of immunopharmacology. 1984, Vol 6, Num 3, pp 147-162, issn 0163-0571Article

Determining Objects, Adjuncts and Complements in EnglishMORLEY, G. D.Word (Worcester). 1991, Vol 42, Num 3, pp 295-302, issn 0043-7956Article

INACTIVATION DU COMPLEMENT PAR LA SALIVE DE SOURIS: DEGRADATION ENZYMATIQUE DE C2, C3, C4, C5 ET C7LECA GERALD.1978; ; FRA; DA. 1978; 58 P.: ILL.; 30 CM; BIBL. 5 P.; TH. UNIV.: SC./PARIS 6/1978Thesis

INACTIVATION OF COMPLEMENT BY MOUSE SALIVA ENZYMATIC DEGRADATION OF C2, C3, C4, C5, AND C7WEILL JC; LECA G; GIRARD JF et al.1979; CLIN. IMMUNOL. IMMUNOPATHOL.; USA; DA. 1979; VOL. 12; NO 4; PP. 425-435; BIBL. 22 REF.Article

The classical complement pathway: activation and regulation of the first complement componentCOOPER, N. R.Advances in immunology. 1985, Vol 37, pp 151-216, issn 0065-2776Article

Carbohydrate composition of the second, third and fifth components and factors B and D of human complementTOMANA, M; NIEMANN, M; GARNER, C et al.Molecular immunology. 1985, Vol 22, Num 2, pp 107-111, issn 0161-5890Article

Activation and fragmentation of the third (C3) and the fourth (C4) components of complement: generation and isolation of physiologically relevant fragments C3c and C4cJANATOVA, J; GOBEL, R. J.Journal of immunological methods. 1985, Vol 85, Num 1, pp 17-26, issn 0022-1759Article

GINGIVAL FLUID ANS SERUM IN PERIODANTAL DISEASES. II. EVIDENCE FOR CLEAVAGE OF COMPLEMENT COMPONENTS C₃, C₃ PROACTIVATOR (FACTOR B) AND C₄ IN GINGIVAL FLUID.SCHENKEIN HA; GENCO RJ.1977; J. PERIODONTOL.; U.S.A.; DA. 1977; VOL. 48; NO 12; PP. 778-784; BIBL. 34 REF.Article

FACTEURS DU COMPLEMENT DANS LE LUPUS ERYTHEMATEUX DISSEMINE.RODRIGO J; GUARDIA J; CABRE VERDIELL J et al.1977; LYON MED.; FR.; DA. 1977; VOL. 238; NO 17; PP. 303-305; ABS. ANGL.; BIBL. 7 REF.Article

KOMPLEMENTSPIEGEL BEI KINDERN MIT IDIOPATHISCH-NEPHROTISCHEM SYNDROM. (C3, C4 UND C3-AKTIVATOR). = LE TAUX DU COMPLEMENT CHEZ LES ENFANTS PRESENTANT UN SYNDROME NEPHROTIQUE IDIOPATHIQUE (C₃, C₄ ET ACTIVATEUR C₃)POLZ E; LUBEC G.1977; PAEDIATR. U. PAEDOL.; OESTERR.; DA. 1977; VOL. 12; NO 4; PP. 360-364; ABS. ANGL.; BIBL. 12 REF.Article

CLINICAL APPLICATIONS OF IMMUNOFIXATION: DETECTION AND QUANTITATION OF COMPLEMENT ACTIVATIONWHICHER JT; HIGGINSON J; RICHES PG et al.1980; J. CLIN. PATHOL.; ISSN 0021-9746; USA; DA. 1980; VOL. 33; NO 8; PP. 781-785; BIBL. 19 REF.Article

BIOSYNTHESIS OF THE COMPLEMENT COMPONENTS AND THE REGULATORY PROTEINS OF THE ALTERNATIVE COMPLEMENT PATHWAY BY HUMAN PERIPHERAL BLOOD MONOCYTESWHALEY K.1980; J. EXPER. MED.; USA; DA. 1980; VOL. 151; NO 3; PP. 501-506; BIBL. 3 P.Article

DEMONSTRATION AND QUANTITATION OF ACTIVATION OF THE FIRST COMPONENT OF COMPLEMENT IN HUMAN SERUM.ZICCARDI RJ; COOPER NR.1978; J. EXPER. MED.; U.S.A.; DA. 1978; VOL. 147; NO 2; PP. 385-395; BIBL. 1 P.Article

FUNCTIONAL AND BIOCHEMICAL PROPERTIES OF THE EARLY CLASSICAL COMPLEMENT SYSTEM OF MICE.GOLDMAN MB; BANGALORE S; GOLDMAN JN et al.1978; J. IMMUNOL.; U.S.A.; DA. 1978; VOL. 120; NO 1; PP. 216-224; BIBL. 20 REF.Article

UNIQUE ROLE OF THE COMPLEMENT RECEPTOR CR₁ IN THE DEGRADATION OF C3B ASSOCIATED WITH IMMUNE COMPLEXESMEDOF M; IIDA K; MOLD C et al.1982; JOURNAL OF EXPERIMENTAL MEDICINE; ISSN 0022-1007; USA; DA. 1982; VOL. 166; NO 6; PP. 1739-1754; BIBL. 48 REF.Article

MODULATION OF THE CLASSICAL PATHWAY C3 CONVERTASE BY PLASMA PROTEINS C4 BINDING PROTEIN AND C3B INACTIVATORGIGLI I; FUJITA T; NUSSENZWEIG V et al.1979; PROC. NATION. ACAD. SCI. U.S.A.; USA; DA. 1979; VOL. 76; NO 12; PP. 6596-6600; BIBL. 33 REF.Article

Synthesis of C3, C5, C6, C7, C8, and C9 by human fibroblastsGARRED, P; HETLAND, G; MOLLNES, T. E et al.Scandinavian journal of immunology (Print). 1990, Vol 32, Num 5, pp 555-560, issn 0300-9475, 6 p.Article

Antibody-independent activation of C1. I: Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesiclesKOVACSOVICS, T. J; PEITSCH, M. C; KRESS, A et al.The Journal of immunology (1950). 1987, Vol 138, Num 6, pp 1864-1870, issn 0022-1767Article

Inhibition of cleavage of the third component of human complement (C3) by its small cleavage fragment, C3a: inhibition occurs with the classical-pathway, but not the alternative-pathway, C3 convertaseSTRUNK, R. C; WEBSTER, R. O.Molecular immunology. 1985, Vol 22, Num 1, pp 37-43, issn 0161-5890Article